BLCM

Bellicum Pharmaceuticals: Narrowing The Thesis And Simplifying The Investment

Bellicum Pharmaceuticals, Inc. (BLCM) CEO Richard Fair on Q4 2020 Results - Earnings Call Transcript

Bellicum Reports Fourth Quarter 2020 Financial Results and Provides Operational Update

Bellicum to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

BLCM Stock Price Increases Over 15% Pre-Market: Why It Happened

BLCM Stock Price Increases Over 40% Pre-Market: Why It Happened

Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial